Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- phosphoric acid, 2,2-dichloroethenyl dimethyl ester
- Correlated keywords
- 8023-22-1 8072-21-7 8072-39-7 8076-16-2 11095-17-3 11096-21-2 11111-31-2 11111-44-7 11126-72-0 12772-40-6 55819-32-4 62139-95-1 62655-59-8 95828-55-0 116788-91-1 Dash Dedevap Des Dichlofos Dichlorman Dichlorovinphos Dichlorovos Divipan ENT20738 ENT-20738 Equigard Equigel Estrosel Estrosol Fecama Fekama Ferag ID TM Insectigas-D Lava-100EC Mopari NSC6738 Nefrafos Nerkol Nogos-500 50EC G Novotox Nuvan-100EC 500EC 7 76EC Nuvos OKO OMS14 OMS-14 Panaplate Phosvit-75 Prima-U SD1750 SD-1750 Szklarniak TAP9VP TAP-9VP Task Unifos-50EC Unitox Vapona Vaponite Vinylofos Vinylophos Winylophos Blattella Bombyx Danio alatox Atgard BAY-b 4986 Bibesol Brevinyl E 50 Canogard Chlorvinphos
- Product Overview:
Dichlorvos is an organophosphate insecticide and inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE; IC50s = 269 and 44 nM, respectively).{38709} It also binds to the M2 muscarinic receptor in rat heart homogenates.{38710} Dichlorvos is lethal to 4-week old German cockroach (B. germanica) nymphs (LD50 = 0.108 ?g per insect) and silkworms (B. mori) in third instar (LC50 = 6.63 mg/L) after 24 hours.{38711,38712} It is lethal to zebrafish (D. rerio) embryos (LC50 = 39.75 mg/L after 24 hours) and decreases swimming activity of larvae 6 days after fertilization when administered at a concentration of 25 mg/L in tank water.{38713} Dichlorvos (150 ppm for 80 weeks) also increases the incidence of benign and malignant neoplasms in male rats from 47 to 88% as compared to controls.{38714}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.